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Abstract
Background: It has been documented that nitric oxide (NO) donor sodium nitroprusside (SNP)
and authentic peroxynitrite are capable of promoting apoptosis in a number of different cell types.
Various endonucleases have been proposed as candidates responsible for the internucleosomal
cleavage of the genomic DNA observed during apoptosis, but the main effect is attributed to the
alkaline-DNases (Mg2+- and caspase-dependent) and acid-DNase. The aim of this study was to
examine an in vivo and in vitro possibility for alkaline- and acid-DNases to be activated by SNP and
peroxynitrite.
Results: The effect on liver tissue alkaline and acid DNase activity together with the markers of
tissue and plasma oxidative and nitrosative stress (lipid peroxidation, SH group content, carbonyl
groups and nitrotyrosine formation) was investigated in plasma and liver tissue. The activity of liver
alkaline DNase increased and that of acid DNase decreased after in vivo treatment with either SNP
or peroxynitrite. A difference observed between the in vivo and in vitro effect of oxide donor (i.e.,
SNP) or peroxynitrite upon alkaline DNase activity existed, and it may be due to the existence of
the "inducible" endonuclease. After a spectrophotometric scan analysis of purified DNA, it was
documented that both SNP and peroxynitrite induce various DNA modifications (nitroguanine
formation being the most important one) whereas DNA fragmentation was not significantly
increased.
Conclusion: Alkaline DNase activation seems to be associated with the programmed destruction
of the genome, leading to the fragmentation of damaged DNA sites. Thus, the elimination of
damaged cells appears to be a likely factor in prevention against mutation and carcinogenesis.
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Background
In its response to tissue damage and inflammation
induced by a variety of xenobiotics, endotoxins and dis-
ease states (such as viral hepatitis), post-ischemic and
regenerative injury, the liver produces a large quantity of
nitric oxide (NO). Nearly all cell types in liver tissue,
including hepatocytes, Kupffer cells, stellate cells and
endothelial cells, have the capacity for generating NO. It
has been documented that NO is capable of promoting
apoptosis in a number of different cell types, generally
classified as cGMP-dependent or cGMP-independent [1-
4]. The potential of chemical NO donor sodium nitro-
prusside (SNP) to induce apoptosis directly from NO lib-
eration has been established in vitro [5]. The fact that NO
is capable of triggering apoptosis is consistent with its
ability to induce DNA damage, the inhibition of DNA
synthesis and cell cycle arrest [6,7]. The reaction product
formed between NO• and superoxide [i.e., peroxynitrite
(ONOO-)] plays a critical role in the induction of inflam-
matory reaction and apoptosis, but is also associated with
tumor promotion and/or progression. Potentially toxic
levels of peroxynitrite can be achieved whenever NO• and
O2
.- production is stimulated, due to the fact that a 100-
fold increase in the rate of peroxynitrite formation occurs
for every 10-fold increase in NO• and O2
.- concentration
[8].
Apoptosis, frequently termed "programmed cell death", is
the form of cell death that occurs in normal liver in the
course of its development and organogenesis, and in adult
liver during the renewal of hepatocytes. In addition, apop-
tosis can be triggered by several hepatotropic viruses and
toxic drugs, as well as in various liver diseases and experi-
mental liver conditions such as hepatic allograft rejection.
Degradation of the nuclear DNA, a common phenome-
non observed in many organisms throughout the evolu-
tionary scale, is one of the best-characterized biochemical
features of apoptotic cell death. It has been established
that the cell undergoes epigenetic reprogramming in the
D1 phase of programmed cell death, the result of which is
the activation of double-stranded DNA fragmentation in
the F phase during which the nuclear morphology dra-
matically changes [9]. The cleavage of DNA may have a
protective function in that it reduces the likelihood for
genes in a potentially active site to be transferred from
dying cells to the nuclei of viable neighboring cells. It is
possible that various endonucleases exert a DNA degrad-
ing activity, as well as that many proteins can receive DNA
degrading properties upon change of pH conditions [11].
The most important aspect of apoptosis is the universal
property of some proteins to exert a dual function: the
protection against proteolysis and the maintenance of the
structure and function of normal cells. Being free from the
inhibitory complex, however, these proteins may also
contribute to protein or chromatin cleavage during apop-
tosis [12,13]. Changes in DNA degradation may lead to
the pathogenesis in various disorders, such as liver cancer
[14,15].
On the basis of the pharmacological data supporting the
critical role of NO and peroxynitrite in apoptosis, current
research studies have evaluated the activity of alkaline and
acid DNase during the administration of SNP or of perox-
ynitrite, as well as the changes in numerous susceptible
parameters of nitrosative stress, including SH group oxi-
dation, carbonyl group formation, lipid peroxidation and
DNA modification. An assay of enzyme activity was per-
formed using liver tissue after in vivo administration and
in vitro treatment of isolated rat hepatocytes or purified
commercial enzymes either with SNP or authentic
peroxynitrite.
Results
There are few data concerning the in vivo susceptibility of
liver tissue to NO donor SNP and authentic peroxynitrite.
A considerable attention has been paid to the establish-
ment of in vivo tolerability and to the markers of apoptotic
effects. Both NO and peroxynitrite can directly react with
aromatic and sulfhydryl nucleophiles and nitrate aro-
matic residues. Sulfhydryl groups oxidation was docu-
mented in the plasma and, almost equally, in liver tissue.
Peroxynitrite administration led to a more pronounced
decrease in the concentration of other plasma free radical
scavengers such as uric acid, and was followed by an
increase in plasma nitrate concentration (Tables 1 and 2).
According to the data suggesting that peroxynitrite
decomposes rapidly to OH• and NO2 
•-like species at
physiological pH, it was assumed that the carbonyl groups
and the lipid peroxidation product [i.e., malondyalde-
hyde (MDA)] may play a significant role in liver cell tox-
icity. Neither plasma nor liver protein carbonyls showed
any significant increase. This may be a likely consequence
of the significant increase in aromatic amino acids nitra-
tion, presumably tyrosine the spectral contribution of
which was substracted from the samples treated with 2,4-
dinitrophenylhidrazine. Plasma and liver MDA concen-
trations were not significantly changed, either. The
obtained results do not support the data suggesting that
oxygen radicals, probably generated during cellular SNP
metabolism, may mediate cell toxicity and apoptosis, but
do confirm previous in vitro observations [16]. Plasma
alanine aminotranferase (ALT) activity, used as the stand-
ard liver functional test, decreased in the peroxynitrite-
treated group (Table 1). The activity of liver alkaline
DNase increased and that of acid DNase decreased after in
vivo treatment with either SNP or peroxynitrite (Table 2).
The ultraviolet spectra of DNA were obtained by spectro-
photometric scanning between 230–500 nm on a scan
detecting system. According to the data by Yermilov et al.Comparative Hepatology 2004, 3:6 http://www.comparative-hepatology.com/content/3/1/6
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[17], the appearance of a peak between 375 and 405 nm
(depending on pH) corresponds to 8-nitroguanine. In the
scan analysis (Figure 1), the peak was between 390 and
410 nm with a maximum absorbance at 405 nm in alka-
line conditions (DNA extract was adjusted to pH 10). This
peak may correspond to the formation of nitro-deriva-
tives, most probably of 8-nitroguanine. The nitroguanine
peak at 405 nm was particularly apparent in peroxynitrite-
treated samples.
In vivo administration of SNP or peroxynitrite tended to
increase the rate of DNA fragmentation, but it was not sta-
tistically significant. The rate was estimated according to
the percentage of DNA resisting centrifugation at 27 000 g
(Table 2).
After in vitro exposure of isolated hepatocytes to SNP or
peroxynitrite, the activity of both alkaline and acid DNase
decreased in a dose-dependent fashion (Figure 2). During
in vitro incubation of purified enzymes DNase I and
DNase II with SNP or peroxynitrite, a dose-dependent
decrease of enzyme activity was also documented (Figure
3).
Discussion
NO•, a free radical gaseous molecule is one of the simplest
compounds found to be continuously produced in
humans and animals. It can be derived from L-arginine
through the enzyme nitric oxide synthase (NOS) and by
different NO donors, including SNP. NO has been shown
to play an unprecedented range of roles in biological sys-
tems, acting as a universal intracellular and transcellular
signaling molecule and the regulator of vascular tone, cell
proliferation and apoptosis [18-20]. Peroxynitrite is a
strong, relatively long-lived oxidant with a half-life of
approximately 0.5–1 s under physiological conditions.
Our study confirmed that in both plasma and liver tissue
peroxynitrite causes a rapid oxidation of sulfhydryl groups
Table 1: Plasma levels of investigated parameters of Sprague-Dawley rats after in vivo treatment with nitric oxide donor (SNP) and 
peroxynitrite. Data expressed as Mean (SD); n = 8 per group.
Parameters Control SNP Peroxynitrite
Lipid peroxidation (MDA) (µmol/l) 7.10 (0.86) 6.78 (2.11) 6.64 (2.85)
SH groups (µmol/l) 180.47 (36.08) 150.84 (4.78) 110.40 (11.96)*
NO2+NO3 (µmol/l) 45.47 (18.80) 66.82 (4.12) 81.94 (10.18)
Uric acid (µmol/l) 64.82 (4.18) 22.34 (8.32) 17.50 (3.21)*
Carbonyl groups (µmol/g protein) 179.59 (28.50) 144.90 (67.40) 169.06 (14.88)
Nitrotyrosine (nmol/g protein) 96.02 (26.53) 136.17 (27.47) 135.11 (4.64)
ALT (U/l) 31.9 (4.15) 34.44 (4.96) 28.5 (5.15)
Male Sprague-Dawley rats three months old were allocated into three different groups. Either peroxynitrite (0.5 ml/kg BW of 30 mmol solution) or 
SNP (10 mg/kg BW) in a volume of 100 µl were administrated in bolus in systemic circulation. The control group received physiological saline 
solution at the same volume. All procedures were carried out as described in Methods. Asterisk: significantly different from the control (p < 0.05).
Table 2: Liver levels of investigated parameters of Sprague-Dawley rats after in vivo treatment with nitric oxide donor (SNP) and 
peroxynitrite. Data expressed as Mean (SD); n = 8 per group.
Parameters Control SNP Peroxynitrite
Lipid peroxidation (MDA) (µmol/g 
protein)
54.42 (8.68) 52.5 (4.34) 58.2 (6.11)
SH groups (µmol/g protein) 636.04 (74.58) 538.67 (82.87) 505.52 (41.43)
NO2+NO3 (µmol/g protein) 6.15 (2.91) 6.04 (2.61) 5.74 (1.03)
Carbonyl groups (µmol/g protein) 4.14 (0.13) 4.25 (0.12) 4.20 (0.26)
Nitrotyrosine (nmol/g protein) 10.26 (2.62) 11.40 (1.24) 16.62 (3.58)
DNA (mg/g tissue) 10.71 (1.75) 12.65 (1.01) 12.15 (1.25)
DNA fragmentation (%) 11.99 (0.33) 13.21 (1.43) 13.0 (0.89)
Alkaline-DNase (U/g protein) 11.95 (0.57) 15.30 (0.72) 16.45 (1.04)
Acid-DNase (U/g protein) 15.28 (3.42) 12.34 (0.35) 9.34 (0.76)
Male Sprague-Dawley rats three months old were allocated into three different groups. Either peroxynitrite (0.5 ml/kg BW of 30 mmol solution) or 
SNP (10 mg/kg BW) in a volume of 100 µl were administrated in bolus in systemic circulation. The control group received physiological saline 
solution at the same volume. All procedures were carried out as described in Methods.Comparative Hepatology 2004, 3:6 http://www.comparative-hepatology.com/content/3/1/6
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and thioethers, as well as the nitration and hydroxylation
of aromatic compounds (Tables 1 and 2). A chronic expo-
sure of hepatocytes to reactive nitrogen species exhibits a
cytotoxic and cytostatic activity leading to functional and
morphological alterations [8,21]. Cell death after expo-
sure to different NO-donors such as SNP has been to date
established through the expression of tumor suppressor
gene p53 and pro-apoptotic genes such as bax, cyclin-
dependent kinase inhibitor p21, the inhibited expression
of anti-apoptotic protein bcl-2, the inhibited NF-κB bind-
ing activity, ERK and p-38-dependent cytochrome c
release, and caspase-3 activation [22-24]. In contrast, the
anti-apoptotic effects of NO may be mediated through the
mechanisms such as blockade of the recruitment of pro-
caspase-9 to the Apaf-1 apoptosome, stimulation of c-
GMP-dependent protein kinase, control of mitochondrial
permeability transition, induction of the heat shock pro-
tein HSP 70, and interaction with the ceramide pathway
[25,26]. The prolonged damage of p53 gene by peroxyni-
trite has been associated with tumor formation. Recent
results by Vincent and Maiese [3] indicate that NO donor
SNP (at 300 µmol concentration) is capable of inducing
strong apoptotic effects via DNA fragmentation and
induction of Mg2+-dependent endonuclease activity in the
culture of neuronal cells. In our in vivo study (Table 2), the
activity of alkaline DNase increased within 24 h after
exposure to SNP (achieving approximately a similar
blood concentration of about 250 µmol) or to authentic
peroxynitrite. Several molecules involved in nuclear DNA
fragmentation have been detected and characterized
based on their ionic sensitivity. Besides the presence of
constitutive Ca2+/Mg2+-dependent endonucleases, a great
deal of endonuclease activity within a 7.2–8.0 pH range
most probably represents the inducible form of DNase.
The molecular weights of the constitutive (NO-independ-
ent) and inducible (NO-dependent) endonuclease are
similar, as well as their optimum pH range (7.5–8.0). A
likely conclusion is that Mg2+-dependent endonuclease
seems to be a result of de novo synthesized or the pre-exist-
ing Ca2+/Mg2+-dependent endonuclease activation. Up to
now, several Mg2+- or Ca2+/Mg2+-dependent alkaline
DNases (DNase I) with an optimum activity within the
range of 7.5–9.5 have been purified. Some of them,
including specific caspase3-activated DNase (CAD), are
active upon release of the specific inhibitor ICAD [27,28].
DNase gamma has been documented as a critical compo-
nent of apoptotic machinery, in that it cleaves the chro-
mosomal DNA into nucleosomal units, thus leading to
DNA ladder formation [29]. The alkaline DNase, active
only during apoptosis, has been documented to be inher-
ent to cyclophilins (A, B and C) as well, irrespective of
their protein folding (peptidylprolyl cis-trans-isomerase)
activity. All of them have the ability to degrade the super-
coiled, single stranded and double stranded DNA [30,31].
Besides alkaline DNases, the cation-independent endonu-
clease with an optimum activity at pH 5, known as acid or
DNase II, was identified. One leucocyte elastase inhibitor
(LEI) can also exert an acid DNase activity after post-trans-
lational modification through the proteolytic cleavage
[32]. The specific involvement of DNase II in physiologi-
cal nuclear degradation during apoptosis could not be
excluded upon decrease of intracellular pH values below
7 with a proton ionophore. Three potential N-nitrosyla-
tion sites are important for DNase II regulation [32,33].
Since our experimental data indicated a decrease in acid
DNase activity 24 h after exposure to SNP or peroxynitrite
(Table 2), the inhibition of DNase II may be explained by
the nitrosylation of its susceptible sites. Indeed, when iso-
lated hepatocytes were exposed to SNP or peroxynitrite for
1 h, a dose-dependent inhibition of DNase II was also
documented (Fig. 2). The same result was obtained after
The peak appearance of isolated liver DNA Figure 1
The peak appearance of isolated liver DNA. The 
extraction oftissue DNA was performed according to the 
method of Wannemacher et al. [50], modified by Setaro & 
Morley [51], with the protein and nucleic acid precipitation 
by using ice-cold trichloroacetic acid after lipid extraction. 
DNA was separated from proteins by hydrolisis of resulting 
pellet at 96 ± 1°C for 45 min. Samples were analyzed for 
DNA concentration by ultraviolet absorption difference at 
260 and 290 nm. Purified DNA was employed for spectral 
changes, monitored by using Beckman spectrophotometer. 
On the basis of the data obtained by Yermilov et al. [13], the 
appearance of a peak between 375 and 405 nm (depending 
on pH) corresponds to 8-nitroguanine. The peak appearance 
was between 390 and 410 nm with the maximum absorbance 
at 405 nm, obtained in alkaline conditions (DNA extract was 
adjusted to pH 10).
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exposure of purified enzyme to SNP (in the presence of
the reducing agent cysteine 1 mmol) or peroxynitrite (Fig.
3).
The formation of 8-nitroguanine, 8-oxo-deoxyguanine
and oxazolone and the oxidative modification of 2'-deox-
yribose into TBA-responsive compounds are the most
prominent nucleotide modifications after reactive nitro-
gen species attack [34,35]. A highly potential mutagenic
product 8-nitroguanine can be depurinated yielding apu-
rinic sites capable of inducing GC→TA transversions,
GC→CG transversions and deletions [17,36]. The appear-
ance of the nitroguanine peak during the scan analysis of
purified DNA at 405 nm was documented in our study
(Fig. 1). The rate of DNA fragmentation tended to be
increased, but the difference was not significant (Table 2).
Conclusions
In vivo administrated SNP and peroxynitrite increase the
activity of alkaline DNase. They also induced DNA modi-
fications, such as nitroguanine formation. The obtained
DNase activation seems to be associated with the
The activity of alkaline and acid DNase after in vitro treatment of isolated hepatocytes with NO donor (SNP) or peroxynitrite Figure 2
The activity of alkaline and acid DNase after in vitro treatment of isolated hepatocytes with NO donor (SNP) 
or peroxynitrite. The isolation of hepatocytes was done according to the method already published [42], by using a 1% colla-
genase dissolved in RPMI 1640 medium. Hepatocytes, isolated from 8 Male Sprague-Dawley rats, were dissolved in a physiolog-
ical saline solution in a concentration of approximately 108cells/ml. They were divided into seven groups (each comprising 8 
samples), exposed to either SNP (0.1, 1 and 10 mmol) or peroxynitrite (0.03, 0.3 and 3 mmol) for a period of 1 hour at 37°C. 
Given in vitro concentrations were calculated according to the literature data [38]. The activity of alkaline and acid-DNase was 
measured by the methods of Bartholeyns et al. [43] and acid soluble nucleotides were determined spectrophotometrically at 
260 nm. The enzyme activity was expressed as U/g protein. Data (n = 8) in graph is putted as: Mean + SD.
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programmed destruction of the genome and cell death.
Given the above results and observations, the elimination
of damaged hepatic cells appears to be a likely factor in
prevention against mutation and carcinogenesis.
Methods
Chemicals
SNP, DNA, DNase I (E.C. 3.1.21.1.) and DNase II (E.C.
3.1.22.1) were obtained from Sigma-Aldrich Company.
RPMI-1640, fetal calf serum (FCS) and collagenase were
purchased from ICN (Costa Mesa, CA). Authentic perox-
ynitrite was freshly synthesized by the quench-flow tech-
nique [37] and its concentration was monitored in
alkaline solution before use in each experiment by meas-
uring the extinction coefficient at 302 nm [38]. All other
chemicals were of the highest purity range.
In vivo study
Twenty-four male Sprague-Dawley rats, three months old,
were divided into three different groups, each comprising
8 animals. Either SNP (10 mg/kg BW) or peroxynitrite
(0.5 ml/kg BW of 30 mmol solution) in a volume of 100
The activity of commercial DNase I and DNase II after in vitro treatment with NO donor (SNP) or peroxynitrite Figure 3
The activity of commercial DNase I and DNase II after in vitro treatment with NO donor (SNP) or peroxyni-
trite. Purified enzymes DNase I (E.C. 3.1.21.1) and DNase II (E.C. 3.1.22.1) were dissolved in physiological saline solution. 
Hepatocytes, isolated from 8 Male Sprague-Dawley rats, were dissolved in a physiological saline solution in a concentration of 
approximately 108 cells/ml. They were divided into seven groups (each comprising 8 samples) exposed to either SNP (0.1, 1 
and 10 mmol) or peroxynitrite (0.03, 0.3 and 3 mmol). The reducing agent (cysteine 1 mmol) was added to SNP to induce in 
vitro NO release [39]. The activity of alkaline and acid-DNase was measured by the methods of Bartholeyns et al. [43] and acid 
soluble nucleotides were determined spectrophotometrically at 260 nm. The defined units for purified DNase I and DNase II 
(increase in absorbance of 0.001/min in a sample containing 0.132 mg DNA, pH 7.4 or pH 5 and 3 ml of reaction mixture) were 
obtained from the Sigma catalogue label. Data (n = 8) in graph is putted as: Mean + SD.
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µl were administrated in bolus in systemic circulation by
intraventricular injection under penthobarbital sodium
anesthesia. The concentrations were calculated according
to the literature data concerning their in vivo tolerability
and in vitro ability to induce apoptotic effects [39,40]. The
calculation of peroxynitrite intra-arterial concentration (6
nmol) was done according to its biological half-life of
about 0.6 s, cardiac output of 40 ml/min/100 g and circu-
lating volume of 20 ml and 250 g of rat BW [41]. The cor-
responding control group received physiological saline
solution in the same volume. The rats were killed 24 h
afterwards, under the same anesthesia. Blood was col-
lected from the abdominal aorta and livers were quickly
removed, frozen and homogenised on ice.
Isolation of hepatocytes
The isolation of hepatocytes was done according to a
method already published [42], by using a 1% colla-
genase dissolved in RPMI 1640 medium. Collagenase was
inhibited by using 10% FCS and cells were washed twice
in physiological saline solution. Hepatocytes were iso-
lated from 8 Male Sprague-Dawley rats. They were dis-
solved in a physiological saline solution in a
concentration approximately 108  cells/ml. They were
divided into seven groups (each comprising 8 samples),
exposed to either SNP (0.1, 1 and 10 mmol) or peroxyni-
trite (0.03, 0.3 and 3 mmol) for a period of 1 hour at
37°C. Given in vitro concentrations were calculated
according to the literature data [38]. Purified enzymes
DNase I and DNase II were dissolved in physiological
saline solution, exposed to the same concentrations of
SNP and peroxynitrite, except that the reducing agent
(cysteine 1 mmol) was added to SNP to induce in vitro NO
release [39].
Methods for alkaline and acid-DNase
The activity of alkaline and acid-DNase was measured by
the methods of Bartholeyns et al. [43] and acid soluble
nucleotides were determined spectrophotometrically at
260 nm. The enzyme activity was expressed as U/g pro-
tein, for tissue and cell samples. The defined units for
purified DNase I and DNase II (increase in absorbance of
0.001 / min in a sample containing 0.132 mg DNA, pH
7.4 or pH 5 and 3 ml of reaction mixture) were obtained
from the Sigma catalogue label.
Extraction of DNA and proteins
The extraction of tissue DNA and proteins was performed
according to the method of Wannemacher et al. [44]
modified by Setaro & Morley [45] by protein and nucleic
acid precipitation using ice-cold trichloroacetic acid
(TCA), 0.6 N, after lipid extraction. RNA and DNA were
isolated by using cold 60% perchloric acid (PCA). DNA
was separated from proteins by hydrolysis of resulting pel-
let at 96 ± 1°C for 45 min after adding 0.5 N PCA. Tissue
protein content was measured according to the Lowry et
al. procedure [46]. Samples were analysed for DNA con-
centration by an ultraviolet absorption difference at 260
and 290 nm. Purified DNA was employed for spectral
changes monitored by using Beckman DU 530 spectro-
photometer. Protein carbonyls and protein nitrotyrosine
were measured in plasma proteins and the remaining pro-
tein pellet according to the method of Oliver et al. [47]
modified by Tien et al. [48]. DNA fragmentation assay was
performed according to the method of Jones et al. [49]
based on the percentage of DNA resisting centrifugation at
27 000 g for 20 min. The proportion is expressed as per-
centage of the total DNA in the uncentrifugated sample.
Protein carbonyls were quantified by spectrophotometric
measurement of their 2,4 dinitrophenylhydrazone deriva-
tives (ε 370 nm = 22000 M-1 cm-1). The difference
between the spectrum of the DNPH-treated sample and
that of the HCl control was determined and expressed as
µmol DNPH/g protein. As nitrotyrosine also absorbs at
370 nm, it was measured according to its spectral contri-
bution at 370 nm. Plasma and tissue SH groups were
measured by using DTMB according to the Elman method
[50]. Plasma and tissue lipid peroxidation product MDA
was measured according to the method of Ohkava et al.
[51]. Nitrates were measured according to the method of
Navarro-Gonzales et al. [52]. Plasma uric acid and ALT
were measured using the Synchron analyzer.
Statistics
Statistical analysis was made with the software SPSS. The
effect of treatments was firstly evaluated by one-way
ANOVA. If there was a significant effect, experimental data
sets were compared against the control group by the Dun-
nett post hoc test. Significance level was set at α = 0.05.
Data were normally distributed with equal variances
among groups.
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